Cost-effectiveness of screening of coronary artery disease in patients with type 2 DIABetes at a very high cardiovascular risk (SCADIAB study) rational and design.
Kamel MohammediNathalie PréaubertTanguy CariouVincent RigalleauNinon FoussardLaurent PiazzaCéline Bairras-MartinThierry CouffinhalJulien BezinAntoine BenardPublished in: Cardiovascular diabetology (2021)
SCADIAB is a large and contemporary RWE study that will assess the economic and clinical impacts of routine CAD screening in T2DM people at a very high cardiovascular risk. It will also evaluate the clinical practice regarding CAD screening and help to make future recommendations and optimize the use of health care resources. Trial registration ClinicalTrials.gov Identifier: NCT04534530 ( https://clinicaltrials.gov/ct2/show/NCT04534530 ).
Keyphrases
- coronary artery disease
- clinical practice
- healthcare
- clinical trial
- randomized controlled trial
- type diabetes
- magnetic resonance imaging
- percutaneous coronary intervention
- cardiovascular events
- heart failure
- magnetic resonance
- atrial fibrillation
- weight loss
- aortic valve
- social media
- phase iii
- phase ii
- current status
- health information